Latest TNBC Stories
Pathway Analysis Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 3, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused
TNBC Comprises About 15-20 Percent of All Breast Cancer Diagnoses; Disproportionately Affects Women of African and Hispanic Descent New York, NY (PRWEB) March
Grassroots Events Across USA on 3.3.14 Focus on Aggressive But Lesser-known Breast Cancer with Disproportionate Impact on Younger Women, African-American Women and Women with BRCA1 Gene Mutation
Triple Negative Breast Cancer Foundation's Second Annual Campaign on 3-3-14 Supports Survivors, Patients and Research of Lesser-known Breast Cancer Norwood,
Singapore, July 27, 2013 - (ACN Newswire) - Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against
- A volcanic mudflow.